A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

Nataly Tarasenko, Suzanne M. Cutts, Don R. Phillips, Gili Berkovitch-Luria, Elinor Bardugo-Nissim, Michal Weitman, Abraham Nudelman, Ada Rephaeli

Biochemical Pharmacology · 2014 · 19 citations · 31 references

Concepts

References

31